Aike Ho

General Partner at ACME Capital · New York City, United States

Invests in AI

AI is one of the sectors on Aike Ho's investor profile, next to Healthcare & Biotech and Digital Health & HealthTech, at seed and early-stage venture. The record holds 4 deals, including Conceivable Life Sciences, Arya Health and Brightside.

Email Investor

Email Investor

Credits to line up before a seed round

Aike Ho backs companies at seed and early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Conceivable Life Sciences
  • Arya Health
  • Brightside
  • Camber

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Digital Health & HealthTech
Rounds
Seed, Early-stage venture
Profile
Venture investor
Deals on record
4
Based in
New York City, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Aike Ho invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Aike Ho's investor profile, together with Healthcare & Biotech and Digital Health & HealthTech. The stages on record are seed and early-stage venture.
Which companies has Aike Ho backed?
The record lists 4 deals, including Conceivable Life Sciences, Arya Health, Brightside and Camber. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Aike Ho?
For a company raising a seed round, AI Perks lists credits such as JetBrains (up to $100,000), MongoDB (up to $25,000), Confluent (up to $20,000) and Massdriver (up to $20,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor